ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

MEDU Medgenics

392.50
0.00 (0.00%)
24 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Medgenics LSE:MEDU London Ordinary Share COM SHS USD0.0001 (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 392.50 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Medgenics Share Discussion Threads

Showing 826 to 849 of 900 messages
Chat Pages: 36  35  34  33  32  31  30  29  28  27  26  25  Older
DateSubjectAuthorDiscuss
16/12/2013
10:25
I haven't Seen any director resignations, so isn't it a case of people being added to the team rather than a change?
scyther
16/12/2013
08:37
I see the shares in US took a bit of a knock Friday so today the share price over here just following suit.

The delay in annoucing the US Trials was disappointing here. I understand there was a change in management and the new team need time to reassess the situation but it seems this has held up progress.

Will look to buy more of these next year if it goes any lower here but for the next couple of months not expecting anything of note here.

The new Management team might have a good track record but just not sure where they plan on taking the company now so will wait for things to settle.

237gmoney
07/11/2013
14:06
Interesting comment in the third quarter results today;

"We are excited to be building upon the Company's strong scientific and technological foundation, and are refining new strategic initiatives to advance the clinical development program in carefully selected specialty and orphan indications," stated Michael Cola

I wonder what these new strategic initiatives are? Partnering with others I hope. Perhaps we will get news in tomorrow's call.

The bad news in the quarter is the $6m loss. At that rate they will run out of cash in 12 months.

pdt
04/11/2013
16:50
I see that there is an investor conference call on Friday. Hopefully there may be hint of business strategy from the new management team, it would be good if they could find some joint venture partners and prove that other big pharma endorse the technology.

I have recently sold a good part of my holding and bought more Immupharma (IMM) since I think there will be positive news on that one over the next month or two. So I actually hope there is not too much progress to report on Friday!

pdt
28/10/2013
18:09
Medgenics Reports Positive Data with Second-Generation Viral Vectors at European Society of Gene and Cell Therapy Congress



Second-generation gene therapy vectors demonstrate improved levels and durability of therapeutic protein secretion in vitro and in vivo



Plans to initiate confirmatory human trials in the first half of 2014

jammytass
23/10/2013
16:54
Weakest news release ever? :D
fanboy1
23/10/2013
16:34
could be a blockbuster cmpy!!!!
jammytass
17/10/2013
20:24
A few months ago I was thinking to myself that perhaps I was investing 10 years too soon in this company. However, the string of appointments, including today's announcement, makes me feel that this company is gearing up for a whole series of deals across a range of protein therapies. I can't see them patiently waiting as we go through phase I to III on our own. As it says in the header the company is aimed at the whole $130 billion plus per year market and the guys associated with it are not the types to sit on their hands and wait. Now feels like a good time to be invested, just my opinion.
pdt
17/10/2013
15:23
Kal, I think your right, some sort of transfer of stock.

The new hire today is pretty serious stuff. Bill worked at Baxters from 1966 to 1987 and left as President. The company now have 10 directors earning serious money and bill will want his options as well.

Next year will certainly be an interesting year here. Thats for sure.

237gmoney
14/10/2013
21:16
Very quiet here as we twiddle our thumbs waiting on news about the start of the US Epodure trial and some interim Infradure trial results due out of Israel.

There was a bit of a bounce in the US today so hopefully that is the end of the recent downward slide.

pdt
02/10/2013
19:22
237gmoney - I could be wrong, but I THINK he was selling them and buying them back in some form of pension or trust - have a look again on the NASDAQ notification and see what you think - so not truly spending more money - it would be nice if he was! Still - he has spent a lot several weeks ago.

Anyone know what period of time, if any, on NSADAQ a director has to ensure there is, between purchasing shares him or herself and an announcement of good or bad news, so as to avoid charges of insider trading? IF there is one, it might give us a clue when the earliest date is the trials/trial results could be announced, working backwards from his original purchase. Under the pretence of 105b director purchace schemes you can basically do it when you want, but I would like to hope MEDGENICs will not be using such tokenism. There is no record of him using a 105b scheme, but I dont know if that has to be published on the notification or not.

kalinit
02/10/2013
13:30
More options awarded to our chairman Mr Barer last night. 450k and 200k by the looks of it. 450k at $10.80 for his wife but still a pretty decent whack.

Loading up before the trials start. Can't be long now.

237gmoney
27/9/2013
20:44
THIS IS GOING TO BE MEGA! EXPECT A WONDERFUL NEWSFLOW OVER THE NEXT FEW WEEKS $20 IS MY SHORT TERM TARGET!
smraynot
26/9/2013
18:42
will kick start again very soon
jammytass
26/9/2013
09:17
Okay, thanks.

Looks like the price may pause now waiting for news.

pdt
26/9/2013
08:34
PDT - sorry yes other news is on the MDGN quote and on their website. Apologies its options not a purchase. I only scan read it at the time.
237gmoney
26/9/2013
08:02
Are you sure thats right? I saw that and it looked like them just granting the options they already talked about?

PDT if you go to the MDGN ticker on ADVFN their is different news for it under financials/quote (i forget which) where you can see the forms.

fanboy1
25/9/2013
13:12
Hi 237gmoney, can I ask where that information is reported? All I can see on the Nasdaq site is the two 20,000 purchases, thanks.
pdt
25/9/2013
09:43
Another director buy announced last night in the US. 25k @ $7 a share. Not messing about over there. They are all loading up before the US Trials are announced.
237gmoney
24/9/2013
18:38
A good article mainly about the new management;

hxxp://seekingalpha.com/article/1708752-new-management-pushes-medgenics-to-forefront-of-gene-therapy?source=nasdaq

I feel even more confident in the prospects for this company having read their bios.

pdt
23/9/2013
18:40
profit takers for sure will bounce up again end of week
jammytass
23/9/2013
14:46
Yeah very odd trades in the US. You can clearly see there were two trades at 1pm today one for 400 @ 7.3 yet it opens down. Maybe delayed trades from friday?

Bound to be some profit takers though as it rose 87% last week.

237gmoney
23/9/2013
14:37
6.79 Down 0.23(3.28%) 9:36AM
jammytass
23/9/2013
14:37
6.79 Down 0.23(3.28%) 9:36AM
jammytass
Chat Pages: 36  35  34  33  32  31  30  29  28  27  26  25  Older

Your Recent History

Delayed Upgrade Clock